Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/13117
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12482]
Metadata
Show full item record
CROSS-SECTIONAL STUDY OF HEPATITIS A VIRUS INFECTION IN THE PANTANAL POPULATION BEFORE VACCINE IMPLEMENTATION IN BRAZIL: USAGE OF NON-INVASIVE SPECIMEN COLLECTION
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Desenvolvimento Tecnológico em Virologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Desenvolvimento Tecnológico em Virologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Universidade Federal de Mato Grosso do Sul. Departamento de Farmácia Bioquímica. Campo Grande, MS, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Desenvolvimento Tecnológico em Virologia. Rio de Janeiro, RJ, Brasil.
Abstract
Population-based prevalence studies are essential tools for screening of hepatitis A and provide important data on susceptible groups. However, surveillance in isolated communities is difficult because of the limited access to these areas and the need for blood sample collection. This study aimed to determine the anti-HAV prevalence using oral fluid samples to provide an alternative tool for epidemiological studies that might be useful for vaccination-related decisions. The study population was composed of 224 volunteers from South Pantanal, aged 3 to 86 years old. This study was performed using oral fluids, previously standardized for anti-HAV antibody detection, which were collected using a ChemBio device. Eluates were tested using modified commercial EIA to detect anti-HAV antibodies. The overall prevalence was 79.1%, corresponding to 178 reactive EIA tests out of 224 samples. The age stratified data revealed a prevalence of 47.8% between 0-10 years, 84% in 11-20 years and 91.9% in subjects older than 21 years. Results indicate that hepatitis A prevalence was higher in adolescents and adults, corroborating the literature reports. Thus, oral fluid samples could replace serum in HAV epidemiological studies in isolated communities as they are efficient at detecting anti-HAV antibodies.
Share